China Merchants Bank (SEHK:03968) Q4 2025 Earnings call March 29, 2026 09:30 PM ET Company ParticipantsGary Lam - Head of Greater China Financials Equity ResearchLi Yuan - Senior JournalistMiao Jianmin - Chairman and Non-Executive DirectorPeng Jiawen - EVP and CFORichard Xu - Managing Director of Equity ResearchWang Liang - President and CEOXia Yangfang - General Manager of the Board of Directors OfficeXie Zhongxiang - News Reporter and Senior JournalistXu Mingjie - EVP and CROYan Meizhi - Managing Director ...

China Merchants Bank (SEHK:03968) Q4 2025 Earnings call March 29, 2026 09:30 PM ET Company ParticipantsGary Lam - Head of Greater China Financials Equity ResearchLi Yuan - Senior JournalistMiao Jianmin - Chairman and Non-Executive DirectorPeng Jiawen - EVP and CFORichard Xu - Managing Director of Equity ResearchWang Liang - President and CEOXia Yangfang - General Manager of the Board of Directors OfficeXie Zhongxiang - News Reporter and Senior JournalistXu Mingjie - EVP and CROYan Meizhi - Managing Director ...

China Merchants Bank (SEHK:03968) Q4 2025 Earnings call March 29, 2026 09:30 PM ET Speaker7Dear investors, analysts, friends from the media, good morning. CMB 2025 annual result announcement will now begin. I am Head of the Office of the Board of Directors of China Merchants Bank, Xia Yangfang. We have released the 2025 annual result last Friday. This conference will be carried out both offline and online webcasting. Now, please allow me to introduce the attendees of today's on-site meeting. Sitting on the ...

Alumis (NasdaqGS:ALMS) Update / briefing March 29, 2026 07:00 PM ET Company ParticipantsAlex Thompson - Managing Director of Biotechnology SectorAndrew Blauvelt - Dermatologist and Psoriasis ExpertChris Yu - VP of Biopharma Equity ResearchChristopher Raymond - Managing DirectorHao Shen - Biotech and Biopharma AssociateIris Gao - Equity Research Senior AssociateJohn Schroer - CFOJörn Drappa - Chief Medical OfficerKatie Degen - Equity Research AssociateMartin Babler - President and CEOConference Call Particip ...

Takeda Pharmaceutical Company (NYSE:TAK) Update / briefing March 28, 2026 08:30 PM ET Company ParticipantsChinwe Ukomadu - Head of Gastrointestinal and Inflammation Therapeutic Area UnitElizabeth Borgeson - Investor Relations OfficerHidemaru Yamaguchi - Managing DirectorHiroyuki Matsubara - Equity Research Senior AssociateJulie Kim - CEO-ElectRhonda Pacheco - President of U.S. Business UnitTony Ren - Head of Asia Healthcare ResearchConference Call ParticipantsSeiji Wakao - Executive Director and Senior Anal ...

Zasocitinib IR Event Phase 3 Psoriasis Data Presented at AAD March 28th, 2026 ET / March 29th, 2026 JST Photo: IFPA | All the Colors We Are This material is prepared and distributed solely for the purpose of providing information about Takeda's management or busine ss to shareholders, investors, and analysts, and is not intended to induce purchase or prescription of any specific drugs and other products. This material is not intended for healthcare professionals, patients, or other persons other than those ...

Boston Scientific (NYSE:BSX) FY Conference March 28, 2026 06:30 PM ET Company ParticipantsBrad Sutton - Chief Medical Officer in AF SolutionsDavid Roman - Managing Director in Global Investment Research DivisionJosh Jennings - Managing DirectorKen Stein - Chief Medical OfficerLauren Tengler - VP of Investor RelationsMarty Leon - Study Co-Chair, Mallah Family Professor of Cardiology, and Chief Innovation OfficerMichael Jaff - Chief Medical Officer in Vascular TherapiesConference Call ParticipantsChris Pasqua ...

Origin Materials (NasdaqCM:ORGN) Q4 2025 Earnings call March 27, 2026 05:00 PM ET Company ParticipantsFrank Mitsch - PresidentJohn Bissell - CEO and Co-founderMatt Plavan - CFO and COOOperatorGood afternoon, and welcome to the Origin Materials fourth quarter 2025 earnings conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask que ...

Origin Materials (NasdaqCM:ORGN) Q4 2025 Earnings call March 27, 2026 05:00 PM ET Company ParticipantsFrank Mitsch - PresidentJohn Bissell - CEO and Co-founderMatt Plavan - CFO and COOOperatorGood afternoon, and welcome to the Origin Materials Fourth Quarter 2025 Earnings Conference Call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask que ...

Origin Materials (NasdaqCM:ORGN) Q4 2025 Earnings call March 27, 2026 05:00 PM ET Speaker3Good afternoon, and welcome to the Origin Materials fourth quarter 2025 earnings conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your telephone keypad. To withdraw your ques ...